From Survivor to Test Pilot: Georgia Tech Alum Helps Refine the Robot That Saved His Life

When Jonathan Sculley first heard the word “robot” in a hospital hallway, he thought it was a joke. The young Georgia Tech graduate was in the middle of a grueling chemo cycle for a rare abdominal sarcoma when a surgeon suggested a robotic‑assisted operation. It sounded like sci‑fi, but the procedure – performed with a Da Vinci‑style platform – cut out the tumor with millimetre precision and, more importantly, spared vital tissue that traditional surgery would have sacrificed.

“I walked out of that OR feeling like I’d just stepped out of a movie set,” Sculley remembers, chuckling. “But the reality was that a robot had literally given me a second shot at life.”

Fast‑forward a few years. Jonathan finished his master’s in biomedical engineering, landed a research assistantship at Georgia Tech’s Institute for Robotics and Intelligent Machines, and now finds himself on the other side of the console. The university is partnering with the robot’s manufacturer to trial a new haptic‑feedback module – a feature that lets surgeons “feel” tissue resistance through the controls.

Because he’s lived through the experience, Sculley brings a perspective no engineer could fake. “I know what the stakes are for a patient lying on that table,” he says, adjusting the instrument arm. “So when I’m asked to rate the smoothness of the instrument’s motion or the intuitiveness of the visual overlay, I’m thinking about real‑world outcomes, not just lab metrics.”

The testing program is modest – a handful of surgeons, a few dozen simulated procedures – but its implications could ripple far beyond the campus. If the haptic feedback proves reliable, future generations of surgical robots might give doctors that extra sensory cue, potentially reducing accidental cuts or unnecessary tissue removal.

For Sculley, the work feels like a full‑circle moment. He’s not just a survivor; he’s a contributor to the very technology that saved him. “It’s kind of poetic,” he admits. “I’m hoping the tweaks we make today will help the next patient feel as lucky as I did.”

While the robotic system is still under regulatory review, the Georgia Tech team is optimistic. They plan to publish their findings later this year and hope the data will accelerate the rollout of the enhanced platform across major medical centres.